Evidence map›Paper›PMID 37273097›Full record

ArticleApplied biochemistry and biotechnology2024

Determination of the Cytotoxicity and Antibiofilm Potential Effect of Equisetum arvense Silver Nanoparticles.

Zeynep Akar, Seref Akay, Nebahat Ejder, Azer Özad Düzgün

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Ameliorative Effect of Herbal Medicine in the Management of Hepatotoxicity.Endocrine, metabolic & immune disorders drug targets · 2025
    Review
  4. Green Synthesis of Ag and Cu Nanoparticles UsingMaterials (Basel, Switzerland) · 2024
    Article
  5. Biogenic AgBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Zeynep AkarDepartment of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, Gumushane University, 29100, Gümüşhane, Turkey.
Seref AkayDepartment of Genetics and Bioengineering, Faculty of Engineering, Alanya Alaaddin Keykubat University, Alanya/Antalya, Turkey.
Nebahat EjderDepartment of Medical Microbiology, Faculty of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.
Azer Özad DüzgünDepartment of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, Gumushane University, 29100, Gümüşhane, Turkey. azerozad@windowslive.com.ORCID http://orcid.org/0000-0002-6301-611X
Gümüşhane University · TRAlanya University · TRRecep Tayyip Erdoğan University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to synthesize and characterize silver nanoparticles (AgNPs) by green synthesis from Equisetum arvense (Ea) extracts and to investigate their cytotoxicity, antibiofilm activity, and α-glucosidase enzyme inhibition. Diverse characterization techniques were applied to verify the production of nanoparticles. SEM examination confirmed that the size of nanoparticles is in the range of 40-60 nm. Also, interactions between silver and natural compounds of plant extract were confirmed through FT-IR and EDX analyses. It was determined that Equisetum arvense silver nanoparticles had antibiofilm activity against three different clinical strains with high biofilm-forming ability. AgNPs reduced the biofilm-forming capacity of clinical A. baumannii isolate with strong biofilm-forming capacity by approximately twofold, while the capacity of clinical K.pneumonaie and E.coli isolates decreased by 1.5 and 1.2 fold, respectively. The α-glucosidase enzyme inhibition potential of the AgNPs, which is determined as 93.50%, was higher than the plant extract with, and the α- 30.37%. MTT was performed to assess whether incubation of nanoparticles with A549 and ARPE-19 cell lines affected their viability, and a dramatic reduction in cell growth inhibition of both A549 and ARPE-19 cells was observed. It has been shown that A549 cells treated with 200 and 150 µg/mL nanoparticles had less cell proliferation compared to control cells at 24-h and 48-h incubation time. According to these results, Ea-derived AgNPs appear to have potential anticancer activity against A549 cancer cells. Investigating the effects of green synthesis nanoparticles on microbial biofilm and various tumors may be important for developing new therapies. The outcomes of this study have showed that Ea-AgNPsmay have a high potential both in the treatment of pathogenic strains that form biofilms, as well as in anticancer therapy use.

Indexed as

EquisetumMetal Nanoparticlesalpha-GlucosidasesAnti-Bacterial AgentsBiofilmsEscherichia coliMicrobial Sensitivity TestsPlant ExtractsSilverSpectroscopy, Fourier Transform Infraredalpha-GlucosidasesAnti-Bacterial AgentsPlant ExtractsSilverAntibiofilmAnticancerGreen synthesisNanotechnologySilver nanoparticle

Identifiers

PMID37273097
OpenAlexW4379376219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.